asoxime chloride has been researched along with Encephalopathy, Toxic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horova, A; Kassa, J; Matouskova, L; Musilek, K; Sepsova, V | 1 |
| Ambert, N; Barbier, L; Baudry, M; Bischoff, S; Bouteiller, JM; Dadak, S; Dorandeu, F; Fagni, L; Greget, R; Lauga, F; Legendre, A; Linossier-Pierre, S; Moussaoui, S; Pernot, F | 1 |
| Karasova, JZ; Kassa, J; Kuca, K; Musilek, K; Tesarova, S | 1 |
| Karasova, JZ; Kassa, J; Tesarova, S | 1 |
| Karasova, JZ; Kassa, J; Misik, J | 1 |
| Bartosova, L; Krejcova-Kunesova, G; Kuca, K | 1 |
| Armstrong, S; Mumford, H; Price, M; Scott, L; Wetherell, J | 1 |
| Karasova, J; Kassa, J | 2 |
9 other study(ies) available for asoxime chloride and Encephalopathy, Toxic
| Article | Year |
|---|---|
A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
Topics: Acetylcholinesterase; Animals; Animals, Outbred Strains; Antidotes; Atropine; Brain; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Mice; Muscarinic Antagonists; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Obidoxime Chloride; Oximes; Pyridinium Compounds; Rats, Wistar; Sarin | 2015 |
Modeling and simulation of organophosphate-induced neurotoxicity: Prediction and validation by experimental studies.
Topics: Acetylcholinesterase; Animals; Brain Waves; Cholinesterase Reactivators; Computer Simulation; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Male; Memantine; Membrane Potentials; Mice; Models, Neurological; Neurons; Neurotoxicity Syndromes; Organophosphates; Oximes; Paraoxon; Pyridinium Compounds | 2016 |
A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats.
Topics: Animals; Atropine; Behavior, Animal; Chemical Warfare Agents; Drug Therapy, Combination; Male; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Soman | 2010 |
A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats.
Topics: Animals; Behavior, Animal; Drug Therapy, Combination; Male; Molecular Structure; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Soman; Trimedoxime | 2011 |
A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
Topics: Animals; Antidotes; Atropine; Autonomic Nervous System; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Czech Republic; Drug Therapy, Combination; Lethal Dose 50; Male; Muscarinic Antagonists; Neurons; Neurotoxicity Syndromes; Obidoxime Chloride; Oximes; Psychomotor Performance; Pyridinium Compounds; Rats; Rats, Wistar; Sarin | 2012 |
Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
Topics: Animals; Antidotes; Behavior, Animal; Chemical Warfare Agents; Injections, Intramuscular; Male; Molecular Structure; Neurotoxicity Syndromes; Organophosphorus Compounds; Oximes; Pralidoxime Compounds; Pyridinium Compounds; Rats; Rats, Wistar | 2005 |
Development of next generation medical countermeasures to nerve agent poisoning.
Topics: Animals; Antidotes; Atropine; Chemical Warfare Agents; Dipeptides; Disease Models, Animal; Drug Therapy, Combination; Guinea Pigs; Ileal Diseases; Intussusception; Lethal Dose 50; Male; Neurotoxicity Syndromes; Oximes; Physostigmine; Pyridinium Compounds; Scopolamine Derivatives; Soman; Time Factors | 2007 |
A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Topics: Animals; Antidotes; Atropine; Behavior, Animal; Butanes; Chemical Warfare Agents; Cholinergic Antagonists; Dose-Response Relationship, Drug; Injections, Intramuscular; Lacrimal Apparatus; Male; Miosis; Molecular Structure; Muscle Tonus; Neurotoxicity Syndromes; Obidoxime Chloride; Organophosphates; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Tears; Time Factors; Toxicity Tests; Treatment Outcome | 2007 |
A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats.
Topics: Animals; Antidotes; Atropine; Autonomic Nervous System; Behavior, Animal; Butanes; Chemical Warfare Agents; Cholinesterase Reactivators; Drug Therapy, Combination; Male; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Obidoxime Chloride; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Soman; Structure-Activity Relationship | 2007 |